Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Martin Wilson

General Counsel at Rocket Pharmaceuticals, Inc. (RCKT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $334K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 15SEC RCKTRocket Pharmaceuticals, Inc. Sell 75,364598,489 held (−11%) $3.40 $256K -24.7%
Aug 20SEC RCKTRocket Pharmaceuticals, Inc. Sell 631673,853 held (−0%) $3.38 $2K -24.3%
Aug 17SEC RCKTRocket Pharmaceuticals, Inc. Sell 3,493674,484 held (−1%) $3.38 $12K -24.3%
May 21SEC RCKTRocket Pharmaceuticals, Inc. Sell 662677,977 held (−0%) $3.01 $2K -15.0%
May 14SEC RCKTRocket Pharmaceuticals, Inc. Sell 3,361678,639 held (−0%) $3.61 $12K -29.1%
Feb 20SEC RCKTRocket Pharmaceuticals, Inc. Sell 1,376682,000 held (−0%) $3.34 $5K -23.4%
Feb 18SEC RCKTRocket Pharmaceuticals, Inc. Sell 12,253683,376 held (−2%) $3.31 $41K -22.7%
Nov 20SEC RCKTRocket Pharmaceuticals, Inc. Sell 1,646383,816 held (−0%) $2.98 $5K -14.1%